New Research PaperCoronaryAbbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial
Coronary
Under an Elsevier user license
open archive
Central Illustration
Key Words
antiplatelet therapy
dual antiplatelet therapy
high bleeding risk
percutaneous coronary intervention
Abbreviations and Acronyms
APT
antiplatelet therapy
BARC
Bleeding Academic Research Consortium
DAPT
dual antiplatelet therapy
HBR
high bleeding risk
MACCE
major adverse cardiac and cerebral event(s)
MI
myocardial infarction
NACE
net adverse clinical outcomes
OAC
oral anticoagulation
PCI
percutaneous coronary intervention
SAPT
single antiplatelet therapy
Cited by (0)
Neal Kleiman, MD, served as Guest Editor of this paper. H. Vernon “Skip” Anderson, MD, served as Guest Editor-in-Chief of this paper.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
© 2023 by the American College of Cardiology Foundation. Published by Elsevier.